Literature DB >> 35661019

Epidemiological Evidence for an Immune Component of Parkinson's Disease.

Paulina Gonzalez-Latapi1, Connie Marras2.   

Abstract

There is a growing interest in the role the immune system and inflammatory response play on the pathophysiology of Parkinson's disease (PD). Epidemiological evidence lends support for the hypothesis that PD is an immune-mediated condition. An association between inflammatory bowel disease, including Crohn's and Ulcerative colitis, and the risk of PD has been described and replicated in several population-based cohorts. Other autoimmune conditions, such as Sjogren syndrome, ankylosing spondylitis, and rheumatoid arthritis also seem to be associated with an increased risk of PD. Immunosuppressant medications seem to be associated with a decreased risk of PD. Finally, variants in genes involved in immune system regulation are also shared between PD and autoimmune conditions. In this review, we will provide an overview of epidemiological evidence from population-based cohort studies, meta-analyses, and genome-wide association studies that analyze the association between the immune system and PD, discuss current gaps in the literature and future research directions in this field.

Entities:  

Keywords:  LRRK2; Parkinson’s disease; autoimmune; epidemiology; immunosuppressants; inflammatory bowel disease

Mesh:

Substances:

Year:  2022        PMID: 35661019      PMCID: PMC9535552          DOI: 10.3233/JPD-223180

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.520


  74 in total

Review 1.  Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis.

Authors:  Vittorio Calabrese; Aurelia Santoro; Daniela Monti; Rosalia Crupi; Rosanna Di Paola; Saverio Latteri; Salvatore Cuzzocrea; Mario Zappia; James Giordano; Edward J Calabrese; Claudio Franceschi
Journal:  Free Radic Biol Med       Date:  2017-11-25       Impact factor: 7.376

Review 2.  Immune system responses in Parkinson's disease: Early and dynamic.

Authors:  Malú G Tansey; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

3.  Humoral cross reactivity between α-synuclein and herpes simplex-1 epitope in Parkinson's disease, a triggering role in the disease?

Authors:  Elisa Caggiu; Kai Paulus; Giannina Arru; Rosanna Piredda; Gian Pietro Sechi; Leonardo A Sechi
Journal:  J Neuroimmunol       Date:  2016-01-09       Impact factor: 3.478

4.  Inflammatory bowel disease increases the risk of Parkinson's disease: a Danish nationwide cohort study 1977-2014.

Authors:  Marie Villumsen; Susana Aznar; Bente Pakkenberg; Tine Jess; Tomasz Brudek
Journal:  Gut       Date:  2018-05-21       Impact factor: 23.059

5.  Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases.

Authors:  Aree Witoelar; Iris E Jansen; Yunpeng Wang; Rahul S Desikan; J Raphael Gibbs; Cornelis Blauwendraat; Wesley K Thompson; Dena G Hernandez; Srdjan Djurovic; Andrew J Schork; Francesco Bettella; David Ellinghaus; Andre Franke; Benedicte A Lie; Linda K McEvoy; Tom H Karlsen; Suzanne Lesage; Huw R Morris; Alexis Brice; Nicholas W Wood; Peter Heutink; John Hardy; Andrew B Singleton; Anders M Dale; Thomas Gasser; Ole A Andreassen; Manu Sharma
Journal:  JAMA Neurol       Date:  2017-07-01       Impact factor: 18.302

6.  Increased risk of Parkinson disease with diabetes mellitus in a population-based study.

Authors:  Yu-Wan Yang; Teng-Fu Hsieh; Chia-Ing Li; Chiu-Shong Liu; Wen-Yuan Lin; Jen-Huai Chiang; Tsai-Chung Li; Cheng-Chieh Lin
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

7.  GI infections are associated with an increased risk of Parkinson's disease.

Authors:  Michael Nerius; Gabriele Doblhammer; Gültekin Tamgüney
Journal:  Gut       Date:  2019-06-14       Impact factor: 23.059

Review 8.  LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson's.

Authors:  Rebecca L Wallings; Mary K Herrick; Malú Gámez Tansey
Journal:  Front Neurosci       Date:  2020-05-21       Impact factor: 4.677

9.  Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression.

Authors:  Harneek Chohan; Konstantin Senkevich; Radhika K Patel; Jonathan P Bestwick; Benjamin M Jacobs; Sara Bandres Ciga; Ziv Gan-Or; Alastair J Noyce
Journal:  Mov Disord       Date:  2021-03-08       Impact factor: 9.698

Review 10.  Aberrations in Peripheral Inflammatory Cytokine Levels in Parkinson Disease: A Systematic Review and Meta-analysis.

Authors:  Xiao-Yan Qin; Shu-Ping Zhang; Chang Cao; Y Peng Loh; Yong Cheng
Journal:  JAMA Neurol       Date:  2016-11-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.